Stephen K. Brannan - Dec 1, 2021 Form 4 Insider Report for Karuna Therapeutics, Inc. (KRTX)

Signature
/s/ Troy Ignelzi, Attorney-in-Fact
Stock symbol
KRTX
Transactions as of
Dec 1, 2021
Transactions value $
-$916,053
Form type
4
Date filed
12/2/2021, 04:20 PM
Previous filing
Nov 3, 2021
Next filing
Jan 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRTX Common Stock Options Exercise $13.6K +2.5K +14.29% $5.45* 20K Dec 1, 2021 Direct
transaction KRTX Common Stock Options Exercise $56.2K +7.73K +38.64% $7.27* 27.7K Dec 1, 2021 Direct
transaction KRTX Common Stock Sale -$986K -7.73K -27.87% $127.57 20K Dec 1, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRTX Option (right to buy) Options Exercise $0 -2.5K -5.13% $0.00 46.2K Dec 1, 2021 Common Stock 2.5K $5.45 Direct F2
transaction KRTX Option (right to buy) Options Exercise $0 -7.73K -16.09% $0.00 40.3K Dec 1, 2021 Common Stock 7.73K $7.27 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 1, 2021.
F2 This option vested as to 25% of the shares on the first anniversary of the vesting commencement date of March 1, 2017, with additional vesting as to 12.5% of the shares underlying the option award at the end of each six month period thereafter.
F3 This option vests as to 12.5% of the shares underlying the option award on each six month anniversary following the vesting commencement date of August 8, 2018.